TAF8-SLC22A16 Fusion FISH Probe
The TAF8-SLC22A16 Fusion FISH Probe is used to confirm a fusion of the TAF8 and SLC22A16 genes. The fusion of the TAF8 and SLC22A16 genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TAF8-SLC22A16-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TAF8-SLC22A16-20-AQAQ | 20 (40 μL) | 200 μL |
|
SLC22A16 Gene Summary
This gene encodes a member of the organic zwitterion transporter protein family which transports carnitine. The encoded protein has also been shown to transport anticancer drugs like bleomycin (PMID: 20037140) successful treatment has been correlated with the level of activity of this transporter in tumor cells. [provided by RefSeq, Dec 2011]
Gene Name: Solute Carrier Family 22 Member 16
Chromosome: CHR6: 110745906 -110797844
Locus: 6q21-q22.1
TAF8 Gene Summary
This gene encodes one of several TATA-binding protein (TBP)-associated factors (TAFs), which are integral subunits of the general transcription factor complex TFIID. TFIID recognizes the core promoter of many genes and nucleates the assembly of a transcription preinitiation complex containing RNA polymerase II and other initiation factors. The protein encoded by this gene contains an H4-like histone fold domain, and interacts with several subunits of TFIID including TBP and the histone-fold protein TAF10. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Gene Name: TATA-box Binding Protein Associated Factor 8
Chromosome: CHR6: 42018250 -42048644
Locus: 6p21.1
Gene Diseases
The TAF8 SLC22A16 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|